FDA Grants Priority Review to Genentech’s Rituxan (Rituximab) in Children with Two Rare Blood Vessel Disorders

World News: . []

Genentech a member of the Roche Group SIX RO ROG OTCQX RHHBY LINK  today that the US Food and Drug Administration FDA has accepted the companys supplemental LINK  License Application sBLA and gran ted Pri...

More news and information about Genentech

Published By:

Business Wire: 06:00 GMT Wednesday 12th June 2019

Published: .

Search for other references to "grants" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us